LBPS $1.65 0%
OLMA $7.10 4.4118%
ODER4.SA $190.00 0%
PBAX $10.81 -0.0924%
BIOX $11.51 3.6937%
SPLG.L $3 509.75 -0.460862%
2288.HK $0.35 1.4493%
BPCP.L $76.70 2.1305%
SPG.NZ $1.29 -1.5267%
8229.HK $0.71 -2.7397%
NXPL $2.68 -4.2857%
LPTH $1.36 0.7407%
0357.HK $14.58 -3.3156%
DCBO $29.68 -2.3684%
MUI $11.51 -0.0521%
PKI $115.82 -2.1543%
0188.HK $0.28 -1.7857%
FLY.PA $71.80 -0.2778%
1009.HK $0.49 5.4348%
YELP $29.56 -0.8054%
HAYN $43.98 0.0227%
PJP $75.68 -0.4754%
1263.HK $4.07 -0.2451%
DFIB.L $9.17 0%
IPSC $3.34 -1.0386%
APQ.L $7.00 7.69231%
1347.HK $25.95 -7.1556%
FSTR $10.97 5.1764%
IPN.PA $112.70 0.5352%
SGOV $100.38 0.0149%
RA $16.55 -0.5709%
DSGX $78.06 -0.4845%
CNF.PA $16.10 0%
D5IU.SI $0.02 0%
TBX $27.79 0.4119%
MDRR $5.65 -7.225%
PHPP.L $11 318.00 -0.8715%
1738.HK $0.62 3.3333%
BRNG.L $3 398.50 -1.0338%
PDT $11.58 -0.5155%
GEPA4.SA $24.99 -0.04%
CGNR.L $17.05 -6.5753%
IEMD.L $6.66 0.6044%
8231.HK $1.39 0%
RYU $115.02 0.1295%
ALAC $12.02 0%
JPGB.L $4 805.00 0%
NVT.L $54.00 -4.4248%
GDR.L $20.25 -1.2195%
CIK $2.79 -0.5357%
EXLS $148.55 -0.8709%
ALUVI.PA $5.02 5.6842%
ONEO $91.23 -0.3207%
RIGS $22.90 0.0874%
0787.HK $0.19 0%
SNSR $30.81 -0.0649%
0K7U.L $18.00 8.14%
UBI.PA $26.09 -2.3578%
1883.HK $3.20 -0.9288%
HIBS $6.15 3.3613%
CNP.PA $20.82 0%
CPI $25.01 -0.2246%
3692.HK $13.00 -2.8401%
JCAG.L $90.72 -3.71461%
AEAE $10.33 0%
EXEL $19.19 -0.8269%
RYTM $16.44 -0.9042%
SCHK $39.41 -0.6804%
OTLY $2.08 -2.1226%
LOTZ $0.15 0%
SIS.L $13.75 1.1029%
0JS0.L $13.24 -0.1297%
SAVE $15.41 -0.9003%
ADRU $21.57 0%
PSA-PI $22.77 0.5742%
1455.HK $0.25 -1.9608%
LAME3.SA $6.62 0%
0TMV.L $52.12 -1.4915%
FTSI $26.49 0%
ATVCU $9.83 0%
ENFA $9.62 0%
TGI $10.11 -1.1253%
BTI $33.63 -1.7241%
DNO $46.08 0%
1719.HK $0.99 0%
IFSD.L $5.70 0.6693%
REG $58.13 -0.6155%
IVCA $10.60 0%
YNGA.L $1 195.00 0.8439%
MDC.L $493.40 -0.4037%
9918.HK $0.93 -3.125%
SIJ $15.49 0.2096%
NBTB $32.03 0.2975%
SPAX $21.28 0%
NSSC $33.22 -1.1604%
IGBH $23.11 -0.302%
PROC.L $26.90 -2.5362%
0978.HK $0.50 0%
6899.HK $0.33 -7.1429%
PCVX $48.89 -2.3277%
Eng
Логотип
Eng
Лого

Oxurion NV 0G99.L

$0.00

-$0 (-13.21%)
На 07:17, 10 мая 2023

Ключевые показатели

  • Marketcap

    2055.00000000

  • week52high

    0.77

  • week52low

    0.01

  • Revenue

  • P/E TTM

    0

  • Beta

    0.38664100

  • EPS

    -0.75900000

  • Last Dividend

    0.28500000

  • Next Earnings Date

    07 мая 2023 г. в 04:58

Описание компании

Oxurion NV, a biopharmaceutical company, develops and commercializes medicines for the treatment of eye diseases in Belgium and internationally. Its lead product is JETREA for the treatment of vitreomacular adhesion/vitreomacular traction. The company also develops THR-149, a plasma kallikrein inhibitor, which is in Phase II clinical trials for the treatment of diabetic macular edema (DME); and THR-687, an integrin antagonist which is in Phase II clinical trials for the treatment of DME. It has collaboration agreements with Bicycle Therapeutics, INC Research, and Galapagos NV. The company was formerly known as ThromboGenics NV and changed its name to Oxurion NV in September 2018. Oxurion NV was founded in 1991 and is headquartered in Leuven, Belgium.

Свежие комментарии

Оставьте свой голос

Анонимное голосование

Будет ли рост российского рынка к концу года?

  • Да

    87%

  • Нет

    12%

Проголосовал 8 человек